Overview

A Blinded, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single Doses of Intravenous Deferiprone in Healthy Volunteers

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

Single center, randomized, double-blind, placebo-controlled, adaptive sequential ascending-dose study for the evaluation of the safety, tolerability, and pharmacokinetics of single doses of deferiprone administered by intravenous infusion to healthy males and females. A bioavailability comparison will be included.

Phase:

Phase 1

Details

Lead Sponsor:

ApoPharma

Treatments:

Deferiprone
Pharmaceutical Solutions